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Wednesday, February 11, 2015 593aby switches of myosin isoforms from IIa to IIx and IIb, with no change in type I
myosin, and to more low molecular weight fast troponin T splice forms. During
reloading, soleus muscle mass, fiber size and contractile force gradually recov-
ered and reached the control level by 15 days. The levels of type IIa, IIx and IIb
myosins recovered at 15 days of reloading. However, fatigue tolerance and post
fatigue force recovery showed a trend of worsening during this period with
significantly inflammatory cell infiltration at 3 and 7 days, indicating reloading
injuries. The reloading injury was accompanied by up-regulations of filamin-C
and alpha-crystallin-B, which returned to control level after 30 days. During the
course of slow recovery, we observed later increases of type I myosin expres-
sion and the number of type I fibers to levels significantly higher than that in
normal adult mouse soleus muscle at 30 to 60 days of reloading, which may
contribute to the recovery of fatigue tolerance. The data demonstrated the value
of increased slow fiber contents as a secondary adaption to compensate for mus-
cle reloading injury, serving as an indicator for monitoring muscle function dur-
ing the chronic recovery from unloading and disuse conditions.
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Myosin II is an ensemble motor that participates in muscle contraction, actin
cortex remodeling and cytokinesis ring constriction. It has been an interesting
puzzle for scientific community to understand the allosteric rules between
motors that regulate/co-ordinate when they work in group. We have performed
classical In Vitromotility assay at different heavy meromyosin (HMM) density
and ATP concentrations. By changing immobilized HMM density and ATP
concentration, we change the number of HMMmolecules available for interac-
tion/unit length of actin filament. Actin filaments of >10 micron length were
added in flow cell and assay was initiated by addition of ATP. Actin filaments
breaks down to smaller pieces within minutes after addition of ATP. Average
length of sliding filaments correlates well with motors density and ATP con-
centrations in solution. At 633 head/mm2 density and 2 mM ATP concentration
the average filament length was 1747.65614 nm and further reduced to
1290.55385.5 nm at 0.1 mM ATP. At 4000 heads/mm2 density and 2 mM
ATP concentration the average filament length was 935.55286 nm and
reduced to 599.55154.2 nm at 0.1 mM ATP. Any filament below this average
length does not slide continuously, they detach from surface with time and any
filament above this average length fragments to smaller pieces with time.
Assuming Poisson distribution of immobilized heads, we calculated maximum
number of molecules that can interact for a given actin length. Number of mol-
ecules required for continuous sliding is independent of motor density and de-
pends only on ATP concentration. For 2 mM ATP concentration, 123.6528.9
heads and for 0.1 mM ATP concentration 62.3 519.5 heads are required for
continuous sliding of actin. All values are mean 5 SD.
Supported by DST, Government of India.
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The myosin converter has been proposed to be critical for setting muscle short-
ening velocity by influencing the amplification of small conformational changes
at the ATPase site into the larger lever arm swing. To test this hypothesis, we
exploited the natural variation of the converter region found inDrosophilamus-
cle types. In Drosophila, a single myosin heavy chain gene is alternatively
spliced to generate myosin isoforms. The converter region is encoded by five
alternative versions of exon 11 that are expressed in different muscle types.
Through genetic modification we forced the expression of the alternative ver-
sions in the Drosophila jump muscle and found that two of the three versions
tested to date, 11a (native to indirect flight muscles) and 11e (embryonic mus-
cles), caused faster maximum shortening velocities of skinned jump muscle fi-
bers relative to the native control 11c. Increases in velocity were primarily
responsible for 70.9% and 79.0% higher power outputs for 11a and 11e fibers,
respectively, because maximum force generation was not significantly different
from control fibers. The fibers expressing 11a and 11e also exhibited a straighter
force-velocity curve, as shown by increased Hill equation parameters a (95.4%
and 84.5% higher, respectively) and b (72.6% and 65.5% higher, respectively)
relative to control fibers, indicating that the converter modulates load dependentcross-bridge kinetics. The higher power and shortening velocity of 11a and 11e
fibers enabled increased jumping ability, 76.0% and 48.8% farther, respectively.
Converter homology models, using the new Drosophila myosin S1 crystal
structure (pdb 4QBD), revealed minimal tertiary structure differences suggest-
ing residue specific interactions with the relay, N-terminus, or essential light
chain are critical. Overall, our data support the hypothesis that the converter
helps set muscle shortening velocity under loaded and unloaded conditions
and thus contributes to muscle fiber type diversity.
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Actin filaments carry out diverse cellular functions including cell division,
intracellular transport, and muscle contraction. Tropomyosin (Tm) is an a-he-
lical coiled-coil protein that regulates actin in most eukaryotic muscle and non-
muscle cells. Nonmuscle isoforms of Tm, particularly Tm5NM1 (Tpm3.1)
(short isoform, 247 a.a., TPM3 gene), play an important role in cellular func-
tions such as cell migration, and cytokinesis as well as in the transformation
and metastasis of cancer cells. In previous work, mutation of evolutionarily-
conserved residues in striated muscle aTm (Tpm1.1) (long isoform, 284 a.a.,
TPM1 gene) revealed the regions important for actomyosin regulation. In the
present study, we have mutated evolutionarily-conserved residues in Tpm3.1
to determine the molecular basis for isoform-specificity of actomyosin regu-
lation by Tms. We mutated surface residues in nonmuscle Tpm3.1 in periods
P1-P7 at positions homologous to the residues that are important for actomy-
osin regulation by striated muscle Tpm1.1 (Barua et al., 2012). In vitro motility
assays were carried out to determine the effect of mutations on actin filament
velocities. Actin-Tm velocities with skeletal myosin are inhibited by Tpm1.1
(~60%) but activated by Tpm3.1 (~60%) relative to actin alone. The Tpm3.1
mutants had little or no effect on velocity, except for the P3 and P6 mutants
that showed a ~50-60% inhibition in filament velocity relative to WT
Tpm3.1. In comparison, amongst the Tpm1.1 mutants, the P3 and P6 mutants
also showed the largest inhibition (~70-80%) in filament velocity relative to
WT Tpm1.1. These results indicate that the same regions of Tm (periods 3
and 6) are important for regulation of skeletal myosin by two different isoforms
that have contrasting effects (inhibition by Tpm1.1 vs. activation by Tpm3.1)
on filament velocity. Supported by NIH.
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Striated muscle tropomyosin is phosphorylated at a single site. Effects of this
covalent modification include an increase in myosin activation by thin fila-
ments (þCa(II)) under steady state conditions (Vmax, 16 vs. 8 sec-1; ionic
strength, ~ 30 mM; T, 25 oC). Thin filaments were assembled using skeletal
muscle troponin and alpha-tropomyosin (either unphosphorylated or phosphor-
ylated). Each type of thin filament was mixed with varying concentrations of
myosin-S1A1 (4uM F-actin; buffer, 5.5 mMMgCl2, 50 mM KCl, 10mM imid-
azole, 3mM MgADP, 1mM dithiothreitol, pH 7 plus 0.5mM EGTA or Ca(II))
and incubated at 4 oC for 1hr with 20uM myokinase inhibitor. The mixtures
were then centrifuged for 30min at 150,000 x g at 25 oC. The unbound S1
was determined using a NH4/EDTA ATPase versus [myosin-S1A1] standard
curve. The zero time samples showed no colour development, consistent
with the absence of ATP. At a given pCa the isotherms obtained with each
type of reconstituted thin filament are virtually superimposable (in terms of
steepness and mid-point). The apparent binding constants range from 0.1 to
0.4 uM. Added Ca(II) strengthens affinity and EGTA weakens it. Pre-steady
state experiments using double-mixing fluorescent stopped-flow are in progress
to investigate further the effect of this modification.
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Mutations in cardiac troponin C (cTnC) have been linked to hypertrophic car-
diomyopathy (HCM) in humans. The cTnC subunit of the troponin complex is
